A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...

A recent study uncovers how drug-resistant cancer cells induce changes in the tumor microenvironment. This phenomenon promotes cancer recurrence and explains why initially effective targeted therapies ...

Health experts, gathering at the U.N., have begun to shift their focus to try to provide access to basic drugs in countries where preventable deaths from infections occur too frequently. By Andrew ...

Despite progress toward controlling malaria, it remains a leading cause of morbidity and mortality, particularly in Africa, where 95% of malaria deaths occur according to the World Health Organization ...

This medium is used to grow malaria parasites. By allowing malaria parasites to evolve over time in controlled conditions and analyzing their genomes, researchers at UC San Diego School of Medicine ...

Leading epidemiologists have warned that continued disruption to foreign aid funding, namely the sudden pause to the US President’s Emergency Plan for AIDS Relief (PEPFAR), could see a rise in the ...

Ovarian cancer treatment faces challenges with high relapse and drug resistance rates, despite initial chemotherapy effectiveness. Cytokines like IL-6 and IL-11 are associated with complex tumor ...